iSpecimen
ISPC • NASDAQ
iSpecimen is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Katharyn Field, with a market cap of $3.4M.
CEOKatharyn Field
Market Cap$3.4M
Medical - Diagnostics & Research
Healthcare
Employees53.0
Websiteispecimen.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for iSpecimen
Date
Monday, April 13, 2026 (in 2 months)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q4 2025
Earnings History
Past 12 earnings reports for iSpecimen
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 17, 2025 | Q3 2025 | -$0.48 | — | $106.6K | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.42 | — | $713.1K | — | 10-Q |
| May 19, 2025 | Q1 2025 | -$0.71Est: -$0.05 | -1320.0% | $1.1MEst: $46.3M | -97.7% | 10-Q |
| Apr 14, 2025 | Q4 2024 | -$6.28Est: -$0.07 | -8871.4% | $1.5MEst: $43.6M | -96.6% | 10-K |
| Nov 7, 2024 | Q3 2024 | -$2.10Est: -$0.19 | -1005.3% | $2.7MEst: $3.0M | -9.8% | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$3.80Est: -$5.60 | +32.1% | $2.9MEst: $2.9M | -0.6% | 10-Q |
| May 7, 2024 | Q1 2024 | -$6.40Est: -$5.40 | -18.5% | $2.3MEst: $2.8M | -19.4% | 10-Q |
| Mar 13, 2024 | Q4 2023 | -$6.80Est: -$4.80 | -41.7% | $2.6MEst: $3.0M | -15.3% | 10-K |
| Nov 2, 2023 | Q3 2023 | -$4.60Est: -$7.00 | +34.3% | $2.8MEst: $2.2M | +24.6% | — |
| Aug 2, 2023 | Q2 2023 | -$7.80Est: -$6.00 | -30.0% | $1.6MEst: $3.1M | -47.1% | 10-Q |
| May 4, 2023 | Q1 2023 | -$5.40Est: -$6.40 | +15.6% | $3.0MEst: $2.6M | +12.6% | 10-Q |
| Mar 14, 2023 | Q4 2022 | -$4.80Est: -$7.40 | +35.1% | $3.0MEst: $2.7M | +10.9% | — |